Search for: All records

Because of its large electrochemical window, acetonitrile (MeCN) is one of the most widely used solvents in electrochemistry. It is a suitable solvent for nonaqueous electrolytes that allows studies of cathodic and anodic processes, but electrolyte purification remains challenging. As received, the high-performance liquid chromatography (HPLC) grade is unsuitable for most electroanalytical applications. We present an approach to optimize the purification of HPLC-grade acetonitrile to yield a tetrabutylammonium perchlorate (TBAP)/MeCN electrolyte for experiments in nonaqueous media. We used cyclic voltammetry (CV) to show the background due to impurities and to guide the experimental design to a background current acceptable for CVs of a 1 mM typical concentration of a redox-active molecule. We use 3A molecular sieves, followed by distillation over CaH2 with a final treatment with Al2O3. The optimized procedure yields CH3CN with small background currents, increasing the signal-to-noise ratio and minimizing chemical complications over a wide potential window. Our approach includes discriminating between impurities in the solvent and electrolyte salts; for TBAP, we recrystallize from ethyl acetate and 95 % ethanol. The process and theoretical guidelines apply to other nonaqueous electrolytes dealing with electroactive impurities, including organic molecules, oxygen, and water. 

Abstract In this work, we utilized a parameterization model of ektacytometry to quantify the bulk rigidity of the rigid red blood cell (RBC) population in sickle cell disease (SCD) patients. Current ektacytometry techniques implement laser diffraction viscometry to estimate the RBC deformability in a whole blood sample. However, the diffraction measurement is an average of all cells present in the measured sample. By coupling an existing parameterization model of ektacytometry to an artificially rigid RBC model, we formulated an innovative system for estimating the average rigidity of the rigid RBC population in SCD blood. We demonstrated that this method could more accurately determine the bulk stiffness of the rigid RBC populations. This information could potentially help develop the ektacytometry technique as a tool for assessing disease severity in SCD patients, offering novel insights into the disease pathology and treatment.